City

Beijing (1)

Condition

Systemic Myasthenia Gravis (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

RemeGen Co., Ltd. (1)

Collaborator

Intervention

rc18 160mg (1)

rc18 240 mg (1)

Study Documents

Intervention Type

biological (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

systemic myasthenia gravis

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Systemic Myasthenia Gravis Trial in Beijing (RC18 160mg, RC18 240 mg)

Active, not recruiting

Systemic Myasthenia Gravis

RC18 160mg
RC18 240 mg

Beijing, Beijing, China

Beijing Tiantan Hospital,Capital Medical University

Jan 9, 2022